Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary Background Screening flexible sigmoidoscopy (FSG) reduces incidence and mortality of colorectal cancer (CRC). Previously reported results from the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had a median follow-up of 12 years. Whether the benefit is sustained over the long-term, and remains so in both sexes and all age groupings is uncertain. We report on long-term results after an additional 5 years of follow-up. Methods Participants in the PLCO (NCT00002540) were recruited from the general population in the catchment areas of 10 screening centers across the US, without previous diagnosis of a PLCO cancer or current cancer treatment. From 1993-2001, the PLCO randomized men and women aged 55-74 years within blocks stratified by center, age and sex to usual care or FSG at baseline and again at 3 or 5 years. The primary endpoint was cause-specific mortality and secondary endpoints included incidence and tumor staging; cause of death was determined without knowledge of study arm. Using an intent-to-treat analysis, we assessed incidence and mortality rates overall, by time-period, and by combinations of sex, age (55-64; 65-74), location (distal/proximal), and stage. Findings After a median follow-up of 15·8 years for incidence (25th 13·2 / 75th 18·0) and 16.8 years (14·4 / 18·9) for mortality, the incidence of CRC was significantly lower in the intervention arm (1461 cases; 12·55 per 10000 person-years (PY)) compared to usual care (1761 cases; 15.33 per 10000 PY; relative risk(RR)=0·82; 95% confidence interval (95%CI) 0·76–0·88). Similarly, mortality was lower in the intervention arm (417 deaths; 3·37 per 10000 PY) than the usual care arm (549; 4·48 per 10000 PY RR=0·75; 95%CI 0·66–0·85). The reduction in mortality was limited to the distal colon, with no significant effect in the proximal colon. Reductions in incidence were significantly larger in men than women (pinteraction=0·04) and reductions in mortality were significantly larger in the older age group (65-74 vs. 55-64 at enrollment; pinteraction=0·01). Interpretation Reduction in CRC incidence and mortality from FSG screening is sustained over the long-term. The benefit is limited to the distal colon, and the benefits are greater in men and in older people. Differences by sex and age should be examined in other ongoing trials of CRC screening to help clarify if different screening strategies would achieve greater risk reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21457 · Cited by 1,944
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Cited by
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.6238 · Cited by 2,034
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Lin, J. S., Perdue, L. A., Henrikson, N. B., Bean, S. I., & Blasi, P. R. (2021) · JAMA · doi:10.1001/jama.2021.4417 · Cited by 650
Cardoso, R., Guo, F., Heisser, T., Hackl, M., Ihle, P., De Schutter, H., Van Damme, N., Valerianova, Z., Atanasov, T., Májek, O., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00199-6 · Cited by 480
Metadata
- Authors
- Miller, E. A., Pinsky, P. F., Schoen, R. E., Prorok, P. C., & Church, T. R.
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 4
- Issue
- 2
- Pages
- 101-110
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W2902995069
- Cited by
- 112
- References
- 3
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial. https://app.cochat.ai/papers/10.1016/s2468-1253(18)30358-3
- The paper
- Miller, E. A., Pinsky, P. F., Schoen, R. E., Prorok, P. C., & Church, T. R. (2019). Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(18)30358-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.